Rigorous Trials, Real Impact - Perfect Clinical Studies

CuralysMD™ has been evaluated in two randomized, double-blind, vehicle-controlled clinical trials in adult and pediatric patients with mild-to-moderate atopic dermatitis (atopic dermatitis), further supported by published real-world evidence and consistent patient-reported outcomes.

Study Design

These insights support the ability of SMRTActiv™ Technology with colloidal oatmeal to address key biological drivers of atopic dermatitis — going beyond symptomatic relief.

Clinical Study Results - Overview

Parameters Adults Pediatrics

(2–17 years old)
Skin Clearance ✔ ✔
Itch Reduction ✔ ✔
Reduce Topical Steroid Use ✔ ✔
Reduce S. aureus on the skin ✔ ✔
Safety in use ✔ ✔

Protocol

Participants:

Adults ≥18 years old

Pediatrics 2–17 years old

Duration of the study:

Adults – 4 weeks with 1 week regression

Pediatrics – 8 weeks

Treatment: 

CuralysMD™ formulation applied twice

daily ± hydrocortisone 2.5% (as needed)

Case Study Report

A published pediatric case report documented rapid improvement of moderate refractory atopic dermatitis within four weeks of twice-daily use of CuralysMD™ moisturizer during ongoing NB-UVB phototherapy. Clinical findings aligned with established barrier-restorative and anti-inflammatory mechanisms described in preclinical research and adult randomized clinical trials.


Clinical findings aligned with established barrier-restorative and anti-inflammatory mechanisms described in preclinical studies and controlled adult clinical trials, with growing supportive evidence in pediatric use.

Clinical Insights. Real Solutions.

Engage with our team to explore the science behind CuralysMD™ and how our platform redefines eczema care through clinically validated barrier-first dermatology.